Raptor Pharmaceuticals (RPTP +4.4%) pokes out a tidy gain after the firm announces that it...

|About: Raptor Pharmaceutical Corp. (RPTP)|By:, SA News Editor

Raptor Pharmaceuticals (RPTP +4.4%) pokes out a tidy gain after the firm announces that it signed a R&D agreement with the National Institutes of Diabetes and Digestive and Lidney Diseases to conduct a Phase 2b clinical trial in Q1 on the efficacy of its RP104 tablet.